UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 67

Sortiert nach

Ionizing Radiation Activates AMP-Activated Kinase (AMPK): A Target for Radiosensitization of Human Cancer Cells

International journal of radiation oncology, biology, physics, 2010-09, Vol.78 (1), p.221-229

2010

Volltextzugriff (PDF)

Role of KRAS and EGFR As Biomarkers of Response to Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21

Journal of clinical oncology, 2008-09, Vol.26 (26), p.4268-4275

2008

Volltextzugriff (PDF)

Neuroanatomical location of brain metastases from solid tumours based on pathology: An analysis of 511 patients with a comparison to the provided clinical history

PloS one, 2023-11, Vol.18 (11), p.e0294154-e0294154

2023

Volltextzugriff (PDF)

The physician factor and anatomical site in 8846 consecutive mediastinal lymph node aspirations in a cross-sectional study

Scientific reports, 2023-01, Vol.13 (1), p.1784-1784, Article 1784

2023

Volltextzugriff (PDF)

Pathologist workload, work distribution and significant absences or departures at a regional hospital laboratory

PloS one, 2022-03, Vol.17 (3), p.e0265905-e0265905

2022

Volltextzugriff (PDF)

Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome

The New England journal of medicine, 2005-07, Vol.353 (2), p.133-144

2005

Volltextzugriff (PDF)

Evolution of anatomic pathology workload from 2011 to 2019 assessed in a regional hospital laboratory via 574,093 pathology reports

PloS one, 2021-06, Vol.16 (6), p.e0253876-e0253876

2021

Volltextzugriff (PDF)

Canadian Multicentric Pan-TRK (CANTRK) Immunohistochemistry Harmonization Study

Modern pathology, 2024-01, Vol.37 (1), p.100384-100384, Article 100384

2024

Volltextzugriff (PDF)

Prostate-Specific Membrane Antigen (PSMA) Expression Predicts Need for Early Treatment in Prostate Cancer Patients Managed with Active Surveillance

International journal of molecular sciences, 2023-11, Vol.24 (22), p.16022

2023

Volltextzugriff (PDF)

Canadian ROS proto-oncogene 1 study (CROS) for multi-institutional implementation of ROS1 testing in non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2021-10, Vol.160, p.127-135

2021

Volltextzugriff (PDF)

Reactive Nodular Fibrous Pseudotumor Mimicking Metastatic Gastrointestinal Stromal Tumor to Perigastric Lymph Node: A Case Report and Review of the Literature

International journal of surgical pathology, 2018-10, Vol.26 (7), p.664-670

2018

Volltextzugriff (PDF)

Novel function of Oncostatin M as a potent tumour‐promoting agent in lung

International journal of cancer, 2015-02, Vol.136 (4), p.831-843

2015

Volltextzugriff (PDF)

Genomic DNA Methylation-Derived Algorithm Enables Accurate Detection of Malignant Prostate Tissues

Frontiers in oncology, 2018-04, Vol.8, p.100-100

2018

Volltextzugriff (PDF)

Canadian Multicenter Project on Standardization of Programmed Death-Ligand 1 Immunohistochemistry 22C3 Laboratory-Developed Tests for Pembrolizumab Therapy in NSCLC

Journal of thoracic oncology, 2020-08, Vol.15 (8), p.1328-1337

2020

Volltextzugriff (PDF)

Phase II Study of Erlotinib in Recurrent or Metastatic Endometrial Cancer: NCIC IND-148

Journal of clinical oncology, 2008-09, Vol.26 (26), p.4319-4325

2008

Volltextzugriff (PDF)

Upregulation of FAM84B during prostate cancer progression

Oncotarget, 2017-03, Vol.8 (12), p.19218-19235

2017

Volltextzugriff (PDF)

Characterization of Proliferating Lesion‐Resident Cells During All Stages of Atherosclerotic Growth

Journal of the American Heart Association, 2016-08, Vol.5 (8), p.n/a

2016

Volltextzugriff (PDF)

Biphasic Alteration of Butyrylcholinesterase (BChE) During Prostate Cancer Development

Translational oncology, 2018-08, Vol.11 (4), p.1012-1022

2018

Volltextzugriff (PDF)

Sulfasalazine-induced cystine starvation: Potential use for prostate cancer therapy

The Prostate, 2007-02, Vol.67 (2), p.162-171

2007

Volltextzugriff (PDF)

PTEN inhibits BMI1 function independently of its phosphatase activity

Molecular cancer, 2009-11, Vol.8 (1), p.98-98, Article 98

2009

Volltextzugriff (PDF)

Establishment in Severe Combined Immunodeficiency Mice of Subrenal Capsule Xenografts and Transplantable Tumor Lines from a Variety of Primary Human Lung Cancers: Potential Models for Studying Tumor Progression–Related Changes

Clinical cancer research, 2006-07, Vol.12 (13), p.4043-4054

2006

Volltextzugriff (PDF)

Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells

Biochimica et biophysica acta, 2011-05, Vol.1813 (5), p.683-694

2011

Volltextzugriff (PDF)

Cost Effectiveness of EML4-ALK Fusion Testing and First-Line Crizotinib Treatment for Patients With Advanced ALK-Positive Non―Small-Cell Lung Cancer

Journal of clinical oncology, 2014-04, Vol.32 (10), p.1012-1019

2014

Volltextzugriff (PDF)

An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line

Laboratory investigation, 2005-11, Vol.85 (11), p.1392-1404

2005

Volltextzugriff (PDF)

Fit-for-Purpose Ki-67 Immunohistochemistry Assays for Breast Cancer

Laboratory investigation, 2024-07, Vol.104 (7), p.102076, Article 102076

2024

Volltextzugriff (PDF)

1 – 25 von 67

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(62)

Publikationsform

Sprache

Englisch
(67)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Ionizing Radiation Activates AMP-Activated Kinase (AMPK): A Target for Radiosensitization of Human Cancer Cells

Role of KRAS and EGFR As Biomarkers of Response to Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21

Neuroanatomical location of brain metastases from solid tumours based on pathology: An analysis of 511 patients with a comparison to the provided clinical history

The physician factor and anatomical site in 8846 consecutive mediastinal lymph node aspirations in a cross-sectional study

Pathologist workload, work distribution and significant absences or departures at a regional hospital laboratory

Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome

Evolution of anatomic pathology workload from 2011 to 2019 assessed in a regional hospital laboratory via 574,093 pathology reports

Canadian Multicentric Pan-TRK (CANTRK) Immunohistochemistry Harmonization Study

Prostate-Specific Membrane Antigen (PSMA) Expression Predicts Need for Early Treatment in Prostate Cancer Patients Managed with Active Surveillance

Canadian ROS proto-oncogene 1 study (CROS) for multi-institutional implementation of ROS1 testing in non-small cell lung cancer

Reactive Nodular Fibrous Pseudotumor Mimicking Metastatic Gastrointestinal Stromal Tumor to Perigastric Lymph Node: A Case Report and Review of the Literature

Novel function of Oncostatin M as a potent tumour‐promoting agent in lung

Genomic DNA Methylation-Derived Algorithm Enables Accurate Detection of Malignant Prostate Tissues

Canadian Multicenter Project on Standardization of Programmed Death-Ligand 1 Immunohistochemistry 22C3 Laboratory-Developed Tests for Pembrolizumab Therapy in NSCLC

Phase II Study of Erlotinib in Recurrent or Metastatic Endometrial Cancer: NCIC IND-148

Upregulation of FAM84B during prostate cancer progression

Characterization of Proliferating Lesion‐Resident Cells During All Stages of Atherosclerotic Growth

Biphasic Alteration of Butyrylcholinesterase (BChE) During Prostate Cancer Development

Sulfasalazine-induced cystine starvation: Potential use for prostate cancer therapy

PTEN inhibits BMI1 function independently of its phosphatase activity

Establishment in Severe Combined Immunodeficiency Mice of Subrenal Capsule Xenografts and Transplantable Tumor Lines from a Variety of Primary Human Lung Cancers: Potential Models for Studying Tumor Progression–Related Changes

Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells

Cost Effectiveness of EML4-ALK Fusion Testing and First-Line Crizotinib Treatment for Patients With Advanced ALK-Positive Non―Small-Cell Lung Cancer

An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line

Fit-for-Purpose Ki-67 Immunohistochemistry Assays for Breast Cancer

Suchergebnisse filtern